Medical Marijuana expanding its presence in Latin AmericaStaff Writer | January 6, 2017
Medical Marijuana, the first-ever publicly traded cannabis company in the U.S., has announced a partnership between their subsidiary HempMeds Brasil and Paragon HealthCare BR, one of the biggest global wholesale distributors of pharmaceutical products.
Medical cooperation HempMeds Brasil and Paragon HealthCare BR
Both pioneers in their respective industries, this newfound partnership provides the opportunity to expose the world to a growing range of products that are showing therapeutic value in international markets.
"This new collaboration with Paragon HealthCare BR is another victory for the hemp industry, and most importantly, for the consumer," said CEO of Medical Marijuana, Dr. Stuart Titus.
"We are truly excited to be a part of this opportunity with HempMeds Brasil and are delighted they selected Paragon HealthCare BR. to become their exclusive distributor for Brasil," said Marcelo Lopes da Silva, VP of International Sales, Paragon Healthcare BR.
This new partnership with Paragon HealthCare BR, will allow HempMeds Brasil to expand its outreach in the industry by providing improved access to people of Latin America.
Paragon HealthCare BR, a specialty pharmaceutical products distributor, has significant relationships with medical professionals, doctor's groups, hospitals, pharmacists and other health care providers.
The venture will focus on making accessibility of products to those in need, assisting individuals to find the medical care needed and then accessing product via special importation permit.
In the long run, this will ultimately reduce the time frame from prescription-to-delivery for patients. ■